Abstract
Our previous study found that Lactobacillus plantarum CCFM639 had the ability to alleviate acute aluminum (Al) toxicity when the strain was introduced simultaneously with Al exposure. This research was designed to elucidate the therapeutic effects of living and dead L. plantarum CCFM639 against chronic Al toxicity and to gain insight into the protection modes of this strain. Animals were assigned into control, Al only, Al + living CCFM639, and Al + dead CCFM639 groups. The Al exposure model was established by drinking water for the first 4 weeks. The strain was given after Al exposure by oral gavage at 109 colony-forming units once per day for 12 weeks. The results show that the Al binding ability of dead CCFM639 was similar to that of living CCFM639 in vitro. The ingestion of living or dead CCFM639 has similar effects on levels of Al and trace element in tissues, but living strains led to more significant amelioration of oxidative stress and improvement of memory deficits in Al-exposed mice. In conclusion, in addition to intestinal Al sequestration, CCFM639 treatment offers direct protection against chronic Al toxicity by alleviation of oxidative stress. Therefore, L. plantarum CCFM639 has a potential as dietary supplement ingredient that provides protection against Al-induced injury.
Introduction
Aluminum (Al) exists throughout nature (in air, water, and plants) and consequently in almost all food [1]. It is also most frequently used in food technology, including packaging materials, food additives, and kitchen utensils [2]. Humans therefore cannot avoid exposure to Al. Once Al is absorbed, it can accumulate in variety of organs [3]. It can cross the blood-brain barrier and accumulate in the brain, causing degeneration of neuronal cells and affecting behavior [4, 5]. Al exposure is thus closely associated with neurodegenerative disorders, including Alzheimer’s disease, Parkinson’s disease, and dialysis encephalopathy [6]. The liver plays a significant role in contaminant storage, redistribution, and detoxification [7]. It is an important early sink for absorbed Al, and Al can be excreted through bile and finally through feces to the outside of body [8, 9], so some researches have also focused on the adverse effects of Al on the liver.
Al is not a redox active metal, but it is pro-oxidant and can induce the formation of reactive oxygen species (ROS), causing oxidative stress and cell damage in diverse tissues, including the liver and brain [10, 11]. Some lactic acid bacteria (LAB) strains have been shown to scavenge ROS and possess antioxidative ability, thus providing protection against oxidative stress and lipid peroxidation [12]. As a very important LAB genera, Lactobacillus has a number of human health benefits[13]. It has been widely used in fermented products that improve total antioxidant status and reduce oxidative stress in healthy individuals [14, 15]. This property may mean that Lactobacillus is a potentially effective tool against Al toxicity.
We recently have found that the probiotic Lactobacillus plantarum CCFM639 can significantly protect mice from acute Al toxicity when the strain was introduced simultaneously with Al exposure [16]. This probiotic can reduce intestinal Al absorption, decrease Al accumulation, and alleviate oxidative stress in tissues. However, it is not clear whether the alleviation of oxidative stress in tissues was simply an indirect effect of the reduction of intestinal Al absorption, a direct effect of the antioxidative property of L. plantarum CCFM639, or both. Therefore, the objective of present study was to elucidate the protections that L. plantarum CCFM639 can offer against chronic Al toxicity in mice and to gain insight into the protective mode of this strain by separating its intestinal Al sequestration capacity and identifying its other potential protective activities.
Materials and methods
Chemicals and kits
All of the assay kits used to measure the activities of superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GPx), alanine transaminase (ALT), and aspartate transaminase (AST) and the levels of glutathione (GSH), malondialdehyde (MDA), blood urea nitrogen (BUN), and creatinine (CRE) were bought from Nanjing Jiancheng Bioengineering Co. Ltd. (Nanjing, China). MRS broth was bought from Hope Bio-Technology Co. Ltd. (Qingdao, China). Aluminum chloride (AlCl3.6H2O) was bought from the Sinopharm Chemical Reagent Co. Ltd. (Shanghai, China).
The strain and preparation
L. plantarum CCFM639 (CGMCC9664) was obtained from the in-house Culture Collections of Food Microbiology (CCFM) of Jiangnan University (Wuxi, China) and cultured as previous study [16, 17]. In order to obtain living and dead CCFM639, cultured biomasses were washed with ultrapure water three times and then divided into two equal portions. One portion, the living biomass, was lyophilized with skim milk and preserved at -20°C. The other portion was boiled at 100°C for 30 min before lyophilization to obtain dead biomass. The viable quantity of biomass was measured and remained approximately at 5×109 colony-forming units (CFU)/mL before it was used in the animal experiments.
Determination of Al binding ability
The Al binding ability of L. plantarum CCFM639 was measured according to a previously used method with minor modifications [18]. The fresh living and dead strains were resuspended in ultrapure water with 5, 50, and 100 mg/L Al ion, respectively, and finally obtained 1g/L of wet bacterial concentration. The samples were incubated at 37°C for 2 h and then centrifuged at 8000 g for 20 min. After centrifugation, the residual Al level in the supernatant was analyzed by inductively coupled plasma mass spectrometry (ICP-MS, NexIon-300X; PerkinElmer) [19]. The background Al concentration was measured by preparing living and dead pellets in ultrapure water instead of Al solution. The final Al binding activity of the strain was assessed after deducting the background Al concentration and expressed as the Al removal rate. They were calculated using the following equation.
Removal rate = [(C1 –C2) ÷ C1] × 100% where C1 and C2 are the initial and residual Al concentration, respectively.
Animal and experimental design
Fifty C57BL/6 mice (male, six week old) weighing 18–25 g were maintained at a controlled temperature and humidity (22°C ± 2°C, 55% ± 10%) with 12 h light/dark cycles. They were fed ad libitum with a standard diet and water. The animal experiments was approved by the Ethics Committee of Jiangnan University, China (JN No. 20150721-1030-51), and all procedures about the care and use of experimental animals followed the guidelines set by the European Community (directive 2010/63/EU).
After one week of adaptation period, the mice were randomly assigned to four different groups of similar mean body weight: control, Al only, Al + living CCFM639, and Al + dead CCFM639 (Table 1). The Al ion was administered in the form of AlCl3.6H2O and provided at a dose of 200 mg/L in drinking water for first four weeks (about 32 mg/kg bw/day Al ion) [20–23]. The water in feeding bottle was refreshed every week. After Al exposure, L. plantarum CCFM639 was provided for another 12 weeks at a dose of 109 CFU in 0.2 mL of skim milk once daily via oral gavage.
Table 1. Design of the animal experiment.
Group (n = 10) | Treament | |
---|---|---|
1–4 weeks | 5–16 weeks | |
Control | PW | PW + SM |
Al only | Al | PW + SM |
Al + living 639 | Al | PW + SM + living 639 |
Al + dead 639 | Al | PW + SM + dead 639 |
PW, plain water for drinking; SM, 0.2 mL skim milk; Al, Al ion at 200 mg/Lin drinking water; SM + 639, 0.2 mL skim milk contained living or dead L. plantarum CCFM639 (1×109 CFU once a day). Animals received skim milkand living or dead L. plantarum CCFM639 via oral gavage.
Ethics statement
The animal experiments was carried out in accordance with the Ethics Committee of Jiangnan University, China (JN No. 20150721-1030-51), and all procedures about the care and use of experimental animals strictly followed the guidelines set by the European Community (directive 2010/63/EU). Each mouse was sacrificed by cervical dislocation with light ether anesthesia, and all efforts were made to minimize suffering.
Sample collection and processing
During the 16-week experiment period, the body weights of the mice were measured every two weeks, and each mouse was transferred to a clean cage for 30 min every two weeks while its feces were collected. On the last day of the experiment and after fasting for 24 h, each mouse was anesthetized with ether and then sacrificed. At necropsy, blood samples were gathered and serum was stored in Eppendorf (EP) tubes. The livers and brains were carefully dissected from each animal and washed with normal saline. The serum and organ samples were preserved at -80°C until processed for following determination. It was executed on all ten mice of each group with a subdivision of serum and organs samples.
Determination of Al and trace elements in tissues and feces
The liver, brain, and feces samples were put into metal-free digestion vessels (Omni, CEM, United Kingdom) and then digested in concentrated nitric acid with the Microwave Digestion System (MARS, CEM, United Kingdom). The levels of Al and trace elements (Fe, Mg, Zn, and Ca) in tissues and the Al level in feces were measured using ICP-MS [24].
Determination of enzyme activities and biochemical indicators in tissues and blood
The livers and brains were assayed for SOD, GPx and CAT activity and MDA and GSH levels. The serum was assayed for ALT and AST activity and BUN and CRE levels. All of the parameters were measured with a commercially available assay kit. The experiments were performed according to the operating instructions provided by the equipment manufacturer.
The Morris water maze test
The Morris water maze (MWM) test was performed as previously reported with minor modifications [25]. The pool was divided into 4 quadrants (I, II, III, and IV), the platform (V) was hidden in the middle of the IV quadrant. It was filled with tap water maintained at approximately 23°C. Each mouse was placed in the water facing the pool wall at a fixed position of each quadrant and allowed to swim freely to the escape platform. Mice had 4 trials per day separated by 40 min for five consecutive days (acquisition test) and permitted to find the hidden platform within 1 min. Once the mouse found the hidden platform, it would stay on it for 10 s. If the mouse could not find it in time, the experimenter would guide it toward the platform. On the sixth day (retrieval test), the platform was removed and the mouse was permitted to swim freely for 1 min. The performance and trajectory of each mouse was recorded by a camera, and the data were analyzed with the ANY-maze software.
Determination of amyloid beta peptide levels in the brain
The levels of amyloid beta peptide (Aβ) 1–40 and Aβ1–42 in the brain were measured with mice enzyme-linked immunosorbent assay kits (Cusabio, USA). The assays were performed according to instructions from the manufacturer.
Statistical Analysis
Statistical analyses were performed using the SPSS software program, version 13.0 (SPSS Inc., Chicago, IL, USA). The experimental data were expressed as mean ± standard error of the mean (SEM). The data were analyzed by one-way analysis of variance. A probability level (p value) of less than 0.05 was considered statistically significant.
Results
The Al binding abilities of living and dead CCFM639 in vitro
The Al binding capacities of living and dead CCFM639 in different initial Al concentrations are shown in Fig 1. When the initial Al concentration was increased from 5 to 100 mg/L, the Al removal rate of L. plantarum CCFM639 was reduced dramatically (p < 0.05). Moreover, the Al binding abilities of living CCFM639 and dead CCFM639 were similar at doses of 50 and 100 mg/L Al ion, but the Al binding ability of the living strain was better than that of the dead strain at the lower Al concentration (p<0.05).
Body weight
The body weight of all mice increased gradually throughout the experiment (Fig 2). In the first four weeks, all mice except for those in the control group grew slowly and they have a similar growth curve. In the following 12 weeks, however, the growth curves of mice in the Al plus living CCFM639 groups is the most closer to those in control group, followed by those in Al plus dead CCFM639 group and Al only group, respectively.
Al levels in the feces
The changes in Al level in the feces of mice are shown in Fig 3. In the control group, the fecal Al levels were very low and remained almost constant. Compared to the control group, the fecal Al content significantly increased in other three groups during the first 4 weeks (p < 0.05). When exposure to Al ceased, the fecal Al content dropped dramatically. Compared with the Al only group, living and dead CCFM639 treatment significantly increased the fecal Al levels at the sixth week (p < 0.05), whereas in the following weeks, the L. plantarum CCFM639 strain had only a slight effect on the fecal Al levels.
Al levels in the livers and brains
The Al levels in the livers and brains are shown in Fig 4. The data of Al levels in the control group are not included because the values were too low to detect. Living CCFM639 treatment significantly decreased the Al concentration in livers, but not in brains (p < 0.05). However, treatment with dead CCFM639 had only slight effect on the Al levels in the livers and brains compared to those in the Al-only group.
The trace elements in liver and brain
As shown in Table 2, Al exposure significantly altered the Fe, Zn and Cu levels in the livers, as well as Fe and Zn levels in the brains (p < 0.05). Treatment with either living or dead CCFM639 could counter these changes, but not significantly, with the exception of the Fe level in Al plus living CCFM639 group. There was no significant difference in Cu level among the four groups in the brian, and the Ca and Mg levels among the groups in both livers and brains.
Table 2. The influence of L. plantarum CCFM639 on levels of trace elements in the livers and brains of mice.
Group | Mean concn (μg/g of wet tissue) | ||||
---|---|---|---|---|---|
Fe | Ca | Zn | Mg | Cu | |
Liver | |||||
Control | 74.92 ± 1.48a | 84.32 ± 2.00a | 34.63 ± 0.89a | 411.68 ± 12.35a | 4.68 ± 0.16a |
Al only | 64.94 ± 1.58b | 82.03 ± 1.68a | 38.78 ± 1.04b | 397.21 ± 10.03a | 5.71 ± 0.23b |
Al + living 639 | 70.84 ± 1.10ab | 83.91 ± 1.66a | 35.86 ± 1.24ab | 405.35 ± 8.90a | 5.13 ± 0.12ab |
Al + dead 639 | 68.79 ± 1.19ab | 82.92 ± 2.14a | 36.06 ± 1.52ab | 396.87 ± 6.81a | 5.47 ± 0.11b |
Brain | |||||
Control | 21.92 ± 0.59a | 30.32 ± 2.37a | 16.63 ± 0.73a | 311.68 ± 6.78a | 5.98 ± 0.15a |
Al only | 19.14 ± 0.47b | 32.03 ± 2.15a | 19.78 ± 0.76b | 331.21 ± 8.64a | 5.82 ± 0.20a |
Al + living 639 | 21.01 ± 0.38a | 31.91 ± 1.66a | 17.86 ± 0.61ab | 319.35 ± 8.03a | 5.87 ± 0.24a |
Al + dead 639 | 20.45 ± 0.56ab | 31.92 ± 1.98a | 18.66 ± 0.68ab | 323.87 ± 5.74a | 5.53 ± 0.27a |
Data are mean ± SEM with ten mice in each group.
a,bThe letters a and b indicate statistically significant differences (p < 0.05) among different groups.
The GSH, MDA, SOD, CAT, and GPx in livers and brains
The changes in GSH, MDA, SOD, GPx, and CAT in livers and brains are presented in Figs 5 and 6. Compared with the control group, SOD, CAT, and GPx activity and GSH level significantly reduced in the livers and brains in the Al only group (p < 0.05), but markedly increased when they were treated with living or dead CCFM639 (p < 0.05). The MDA level increased in the Al only group in both the liver and brain (p < 0.05). Treatment with living or dead CCFM639 can reverse this parameter toward control levels (p < 0.05). However, it is worth noting that the living CCFM639 had a better protective effect than the dead CCFM639 on GSH, MDA, and SOD (p < 0.05).
The BUN, CRE, ALT, and AST in serums
As shown in Table 3, the BUN level in serum was significantly elevated in the Al only group and was accompanied by increases in the CRE level and in ALT and AST activities (p < 0.05). Treatment with living or dead CCFM639 observably alleviated the alteration of these parameters (p < 0.05), with the exception of the BUN level.
Table 3. The influence of L. plantarum CCFM639 on Al-induced alterations of the enzyme activities of ALT and AST, and the levels of BUN and CRE in the serum.
Group | Mean level (/liter serum) | Mean activity (U/liter serum) | ||
---|---|---|---|---|
BUN (mmol) | CRE (μmol) | ALT | AST | |
Control | 3.58 ± 0.24a | 56.40 ± 1.80a | 36.52 ± 0.85a | 67.15 ± 1.86a |
Al only | 4.68 ± 0.32b | 86.88 ± 2.94b | 73.71 ± 2.23b | 115.82 ± 3.54b |
Al + living 639 | 3.94 ± 0.19ab | 66.37 ± 2.86ac | 46.15 ± 1.61c | 86.08 ± 2.13c |
Al + dead 639 | 4.02 ± 0.21ab | 71.76 ± 3.52c | 50.16 ± 0.73c | 90.60 ± 1.73c |
Data are mean ± SEM with ten mice in each group.
a,b,cThe letters a, b and c indicate statistically significant differences (p < 0.05) among different groups.
Morris water maze test
During the five training days, the escape latency of the mice in the Al + living or dead CCFM639 group showed greater improvement than those in the Al only group (Fig 7A). The mean escape latency of the Al only group was significantly higher than those of the other three groups after the second day (p < 0.05). Moreover, the platform crossing times and the distance travelled and time spent in the target quadrant were markedly lower for the Al only group than for the control and Al + living CCFM639 groups (p < 0.05). No significant differences were observed between the Al only and Al + dead CCFM639 groups (Fig 7B and 7C). The patterns of movement in Fig 7D show the trajectories followed by mice of different groups at the sixth day, which clearly show that the mice in the Al only group took more time to locate the hidden platform. In contrast, the mice in the Al + living CCFM639 group located the hidden platform more quickly, followed by those in the Al + dead CCFM639 groups. Moreover, when the platform was removed, the mice in the Al only group always swam along the wall, whereas those in the other three groups swam in the target quadrant. The performances of the mice in the Al + living CCFM639 group were better than those in the Al + dead CCFM639 group.
Amyloid beta levels in the brains
The changes in the amyloid beta (Aβ) levels in the brain are presented in Fig 8. Al dramatically increased the levels of Aβ1–40 and Aβ1–42 in the brain (p < 0.05). After living CCFM639 treatment, the two parameters were significantly reduced (p < 0.05). No significant changes were observed between the Al only and Al + dead CCFM639 groups.
Discussion
Lactobacillus plantarum CCFM639 was shown to alleviate acute Al toxicity in mice in our previous study [16]. It is important and necessary to investigate the protective abilities of L. plantarum CCFM639 against chronic Al toxicity because chronic Al exposure is a great threat to human and animal health [26]. To imitate chronic Al exposure, we orally introduced Al via drinking water, and the Al concentration was derived from previous studies [17]. Moreover, the intestinal Al sequestration ability of L. plantarum CCFM639 appeared to be important in previous studies because it can decrease Al absorption in the intestine, thereby reducing Al levels in other tissues. However, it was not clear whether the protective effects of this strain were a result of this protection route or any other routes. Therefore, in this study, we avoided the sequestration route by introducing Al into mice in first four weeks and then administered L. plantarum CCFM639, thus avoiding direct contact between Al and the strain in the intestine. After accumulating in the liver, a small amount of Al is re-excreted into the intestine through bile and then reabsorbed by enterocyte or excreted via the feces [2, 9]. It is thus possible that L. plantarum CCFM639 in the intestine may bind the re-excreted Al, which is then be excreted via the feces before intestinal re-absorption. This could account for the significant increase of fecal Al levels in the Al + living and dead CCFM639 group in the sixth week, even though there was no direct contact between Al and L. plantarum CCFM639 (Fig 3).
Several antioxidant enzymes, including CAT, SOD and GPx are crucial in the cellular defense against ROS and free radicals [27]. Previous research showed that Al exposure led to oxidative stress with a decrease in SOD, GPx and CAT activity and the GSH level, and a higher level of MDA [28, 29]. One proposed mechanism by which Al modifies the activities of antioxidant enzymes is its capacity to interact with essential trace metals [30–32]. Mg, Zn and Cu are the cofactors of SOD. Cu overload causes obvious oxidative stress damage [33]. Chronic Cu overload would cause Fe overload, it results increases in AST and ALT levels, as well as in MDA content [34]. Studies have shown that appropriate supplementation of Zn was effective in alleviating tissue damage caused by Al exposure, possibly due to activation of Zn-SOD, which decreases Al induced oxidative stress injury [35]. Imbalances in Al, Fe, Cu and Zn levels caused by Al overload can lead to obvious oxidative stress in liver, which further results in damage to hepatic cells and liver dysfunction [36]. Probiotic can alleviate Al toxicity via many mechanisms such as reducing oxidative stress, inhibiting NO synthase-2 expression and so on [37, 38]. When NO is produced in excess, it causes deleterious effect indirectly through the creation of reactive nitric oxygen species (RNOS), responsible for the oxidative stress. NO has been implicated as a pathogenic mediator in a variety of conditions, such as Alzheimer’ diseases [39, 40]. The possible antioxidative mechanisms of LAB may involve scavenging of ROS, possessing reducing activity and regulating trace elements [12]. It is noticeable that L. plantarum CCFM639 elevated the GPx, SOD, and CAT activity; decreased the MDA level, and increased GSH level, which are associated with antioxidant defense systems. Living L. plantarum CCFM639 had a greater antioxidative effect than the dead strain. One reason may be that the living strain can improve the absorption and bioavailability of trace elements [41–43]. Moreover, AST, ALT, CRE and BUN, the biomarkers of hepatic and renal injuries [29, 44], were also alleviated by living and dead CCFM639.
There is increasing evidence to indicate that Al is a neurotoxic metal and may cause learning and memory impairment [23, 45]. Al expsoure leads to amyloid beta (Aβ) peptide accumulation in the brain. Increased Aβ can induce ROS generation, and ROS causes oxidative stress and thus deteriorates the learning ablility and cognitive function [10, 46, 47]. Many studies indicate that oxidative stress is an important factor in the development and progression of Alzheimer’ diseases [48, 49]. Mounting evidence suggests that ingestion of probiotics, including Lactobacillus and Bifidobacteria, increases memory function and improves cognition via the gut-brain axis [50–53]. The Morris water maze is a useful tool for evaluation of learning and memory in mice [54]. Our results in this study demonstrate that L. plantarum CCFM639 can alleviate cerebral oxidative stress in the mice. The alleviations subsequently improved memory deficits of Al-exposed mice and decreased Aβ accumulation in the brain. These results are consistent with recent findings confirming that probiotics supplementation may affect physiology and behavior in both diseased and healthy states [55].
In addition, the differences between mice in the Al + living and the dead CCFM639 groups provide insight into the protection of L. plantarum CCFM639 against chronic Al toxicity. Taking all effects of fecal Al excretion, tissue Al accumulation, and oxidative stress into consideration, living CCFM639 treatment offers the best protection against chronic Al toxicity. Living CCFM639 can stimulate intestinal peristalsis, increase the absorption of essential elements and alleviate oxidative stress directly, whereas the dead strain may not have these properties. Therefore, our results show that living and dead CCFM639 strains have similar Al binding ability in vitro, but living strain treatment had more protective effects than dead strain treatment in animal experiments (Fig 9).
Conclusion
Living and dead L. plantarum CCFM639 treatment offers direct protection against chronic Al toxicity by alleviating oxidative stress besides intestinal Al sequestration, and living L. plantarum CCFM639 provides better protection than the dead strain. L. plantarum CCFM639 thus has potential to be a supplementary dietary ingredient for alleviating chronic Al toxicity.
Data Availability
All relevant data are within the paper.
Funding Statement
This work was supported by the National Natural Science Foundation of China [grant number 31371721]; the National Natural Science Foundation of China Key Program [grant numbers 31530056]; the National Natural Science Foundation of China [grant numbers 31601452]; the National Natural Science Foundation of China [grant numbers 31470161]; the National Natural Science Foundation of Jiangsu Province [grant number BK20160175]; BBSRC Newton Fund Joint Centre Award, the Self-determined Research Program of Jiangnan University [grant numbers JUSRP 115A23]; Grain Industry Research Special Funds for Public Welfare Projects [grant numbers 201513006-03].
References
- 1.Kumar V, Gill KD. Aluminium neurotoxicity: neurobehavioural and oxidative aspects. Arch Toxicol. 2009;83(11):965–78. 10.1007/s00204-009-0455-6 [DOI] [PubMed] [Google Scholar]
- 2.Aguilar HA F, Barlow S, Castle L, Crebelli R, Dekant W, Engel K-H, et al. Scientific Opinion of the Panel on Food Additives, Flavourings, Processing Aids and Food Contact Materials on a request from European Commission on Safety of aluminium from dietary intake. The EFSA Journal. 2008; 754: 1–34 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Ward RJ, Zhang Y, Crichton RR. Aluminium toxicity and iron homeostasis. J Inorg Biochem. 2001;87(1–2):9–14. [DOI] [PubMed] [Google Scholar]
- 4.Bharathi, Shamasundar NM, Sathyanarayana Rao TS, Dhanunjaya Naidu M, Ravid R, Rao KS. A new insight on Al-maltolate-treated aged rabbit as Alzheimer's animal model. Brain Res Rev. 2006;52(2):275–92. 10.1016/j.brainresrev.2006.04.003 [DOI] [PubMed] [Google Scholar]
- 5.Yokel RA, Wilson M, Harris WR, Halestrap AP. Aluminum citrate uptake by immortalized brain endothelial cells: implications for its blood-brain barrier transport. Brain Res. 2002;930(1–2):101–10. [DOI] [PubMed] [Google Scholar]
- 6.Kumar V, Gill KD. Aluminium neurotoxicity: neurobehavioural and oxidative aspects. Arch Toxicol. 2009;83(11):965–78. 10.1007/s00204-009-0455-6 [DOI] [PubMed] [Google Scholar]
- 7.Sivakumar S, Khatiwada CP, Sivasubramanian J. Bioaccumulations of aluminum and the effects of chelating agents on different organs of Cirrhinus mrigala. Environ Toxicol Pharmacol. 2012;34(3):791–800. 10.1016/j.etap.2012.09.007 [DOI] [PubMed] [Google Scholar]
- 8.Stacchiotti A, Lavazza A, Ferroni M, Sberveglieri G, Bianchi R, Rezzani R, et al. Effects of aluminium sulphate in the mouse liver: similarities to the aging process. Exp Gerontol. 2008;43(4):330–8. 10.1016/j.exger.2008.01.009 [DOI] [PubMed] [Google Scholar]
- 9.Exley C, Burgess E, Day JP, Jeffery EH, Melethil S, Yokel RA. Aluminum toxicokinetics. Environ Health Toxicol. 1996;48(6):569–84. [DOI] [PubMed] [Google Scholar]
- 10.Zatta P, Kiss T, Suwalsky M, Berthon G. Aluminium(III) as a promoter of cellular oxidation. Coord Chem Rev. 2002;228(2):271–84. [Google Scholar]
- 11.Chen SM, Fan CC, Chiue MS, Chou C, Chen JH, Hseu RS. Hemodynamic and Neuropathological Analysis in Rats with Aluminum Trichloride-Induced Alzheimer's Disease. PloS one. 2013;8(12). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Lin MY, Yen CL. Antioxidative ability of lactic acid bacteria. J Agr Food Chem. 1999;47(4):1460–6. [DOI] [PubMed] [Google Scholar]
- 13.Amaretti A, di Nunzio M, Pompei A, Raimondi S, Rossi M, Bordoni A. Antioxidant properties of potentially probiotic bacteria: in vitro and in vivo activities. Appl Microbiol Biotechnol. 2013;97(2):809–17. 10.1007/s00253-012-4241-7 [DOI] [PubMed] [Google Scholar]
- 14.Naruszewicz M, Johansson M-L, Zapolska-Downar D, Bukowska H. Effect of Lactobacillus plantarum 299v on cardiovascular disease risk factors in smokers. Am J Clin Nutr. 2002;76(6):1249–55. [DOI] [PubMed] [Google Scholar]
- 15.Songisepp E, Kals J, Kullisaar T, Mändar R, Hütt P, Zilmer M, et al. Evaluation of the functional efficacy of an antioxidative probiotic in healthy volunteers. Nutr J. 2005;4(1):1. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Yu L, Zhai Q, Liu X, Wang G, Zhang Q, Zhao J, et al. Lactobacillus plantarum CCFM639 alleviates chronic aluminum toxicity in mice. Appl Microbiol Biotechnol. 2016;100(4): 1891–1900. [DOI] [PubMed] [Google Scholar]
- 17.Yu L, Zhai Q, Yin R, Li P, Tian f, Liu X, et al. Lactobacillus plantarum CCFM639 alleviate trace element imbalance-related oxidative stress in liver and kidney of chronic aluminum exposure mice. Biol Trace Elem Res. 2017;176(2): 342–9. 10.1007/s12011-016-0843-8 [DOI] [PubMed] [Google Scholar]
- 18.Halttunen T, Collado MC, El-Nezami H, Meriluoto J, Salminen S. Combining strains of lactic acid bacteria may reduce their toxin and heavy metal removal efficiency from aqueous solution. Lett Appl Microbiol. 2008;46(2):160–5. 10.1111/j.1472-765X.2007.02276.x [DOI] [PubMed] [Google Scholar]
- 19.Park E-J, Sim J, Kim Y, Han BS, Yoon C, Lee S, et al. A 13-week repeated-dose oral toxicity and bioaccumulation of aluminum oxide nanoparticles in mice. Arch Toxicol. 2015;89(3):371–9. 10.1007/s00204-014-1256-0 [DOI] [PubMed] [Google Scholar]
- 20.Sethi P, Jyoti A, Hussain E, Sharma D. Curcumin attenuates aluminium-induced functional neurotoxicity in rats. Pharmacol Biochem Behav. 2009;93(1):31–9. 10.1016/j.pbb.2009.04.005 [DOI] [PubMed] [Google Scholar]
- 21.Kumar A, Dogra S, Prakash A. Protective effect of curcumin (Curcuma longa), against aluminium toxicity: Possible behavioral and biochemical alterations in rats. Behav Brain Res. 2009;205(2):384–90. 10.1016/j.bbr.2009.07.012 [DOI] [PubMed] [Google Scholar]
- 22.Linardaki ZI, Orkoula MG, Kokkosis AG, Lamari FN, Margarity M. Investigation of the neuroprotective action of saffron (Crocus sativus L.) in aluminum-exposed adult mice through behavioral and neurobiochemical assessment. Food Chem Toxicol. 2013;52:163–70. 10.1016/j.fct.2012.11.016 [DOI] [PubMed] [Google Scholar]
- 23.Prakash D, Gopinath K, Sudhandiran G. Fisetin Enhances Behavioral Performances and Attenuates Reactive Gliosis and Inflammation During Aluminum Chloride-Induced Neurotoxicity. Neuromolecular Med. 2013;15(1):192–208. 10.1007/s12017-012-8210-1 [DOI] [PubMed] [Google Scholar]
- 24.Park EJ, Umh HN, Kim SW, Cho MH, Kim JH, Kim Y. ERK pathway is activated in bare-FeNPs-induced autophagy. Arch Toxicol. 2014;88(2):323–36. 10.1007/s00204-013-1134-1 [DOI] [PubMed] [Google Scholar]
- 25.Ribes D, Colomina MT, Vicens P, Domingo JL. Effects of oral aluminum exposure on behavior and neurogenesis in a transgenic mouse model of Alzheimer's disease. Exp Neurol. 2008;214(2):293–300. 10.1016/j.expneurol.2008.08.017 [DOI] [PubMed] [Google Scholar]
- 26.Toxicological profile for aluminum2001. DIANE Publishing Company p.
- 27.Apel K, Hirt H. Reactive oxygen species: metabolism, oxidative stress, and signal transduction. Annu Rev Plant Biol. 2004;55:373–99. 10.1146/annurev.arplant.55.031903.141701 [DOI] [PubMed] [Google Scholar]
- 28.Rui D, Yongjian Y. Aluminum chloride induced oxidative damage on cells derived from hippocampus and cortex of ICR mice. Brain Res. 2010;1324:96–102. 10.1016/j.brainres.2010.02.024 [DOI] [PubMed] [Google Scholar]
- 29.Mahieu S, Contini Mdel C, Gonzalez M, Millen N. Melatonin reduces oxidative damage induced by aluminium in rat kidney. Toxicol Lett. 2009;190(1):9–15. 10.1016/j.toxlet.2009.06.852 [DOI] [PubMed] [Google Scholar]
- 30.Guo C, Wang C. Plasma aluminum is a risk factor for oxidative stress and inflammation status in hemodialysis patients. Clin Biochem. 2011;44(16):1309–14. 10.1016/j.clinbiochem.2011.08.1132 [DOI] [PubMed] [Google Scholar]
- 31.Zhu Y, Li X, Chen C, Wang F, Li J, Hu C, et al. Effects of aluminum trichloride on the trace elements and cytokines in the spleen of rats. Food Chem Toxicol. 2012;50(8):2911–5. 10.1016/j.fct.2012.05.041 [DOI] [PubMed] [Google Scholar]
- 32.Culotta VC, Yang M, O'Halloran TV. Activation of superoxide dismutases: putting the metal to the pedal. Biochim Biophys Acta. 2006;1763(7):747–58. 10.1016/j.bbamcr.2006.05.003 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Ozcelik D, Ozaras R, Gurel Z, Uzun H, Aydin S. Copper-mediated oxidative stress in rat liver. Biol Trace Elem Res. 2003;96(1–3):209–15. 10.1385/BTER:96:1-3:209 [DOI] [PubMed] [Google Scholar]
- 34.Malhi H, Joseph B, Schilsky ML, Gupta S. Development of cell therapy strategies to overcome copper toxicity in the LEC rat model of Wilson disease. Regen Med. 2008;3(2):165–73. 10.2217/17460751.3.2.165 [DOI] [PubMed] [Google Scholar]
- 35.Bhasin P, Singla N, Dhawan DK. Protective Role of Zinc During Aluminum-Induced Hepatotoxicity. Environ Toxicol. 2014;29(3):320–7. 10.1002/tox.21760 [DOI] [PubMed] [Google Scholar]
- 36.Yang Y, Wang H, Guo Y, Lei W, Wang J, Hu X, et al. Metal Ion Imbalance-Related Oxidative Stress Is Involved in the Mechanisms of Liver Injury in a Rat Model of Chronic Aluminum Exposure. Biol Trace Elem Res. 2016. [DOI] [PubMed] [Google Scholar]
- 37.Toumi R, Soufli I, Rafa H, Belkhelfa M, Biad A, Touil-Boukoffa C. Probiotic bacteria lactobacillus and bifidobacterium attenuate inflammation in dextran sulfate sodium-induced experimental colitis in mice. Int J Immunopathol Pharmacol. 2014;27(4):615–27. 10.1177/039463201402700418 [DOI] [PubMed] [Google Scholar]
- 38.Toumi R, Abdelouhab K, Rafa H, Soufli I, Raissi-Kerboua D, Djeraba Z, et al. Beneficial role of the probiotic mixture Ultrabiotique on maintaining the integrity of intestinal mucosal barrier in DSS-induced experimental colitis. Immunopharmacol Immunotoxicol. 2013;35(3):403–9. 10.3109/08923973.2013.790413 [DOI] [PubMed] [Google Scholar]
- 39.Belkhelfa M, Rafa H, Medjeber O, Arroul-Lammali A, Behairi N, Abada-Bendib M, et al. IFN-gamma and TNF-alpha are involved during Alzheimer disease progression and correlate with nitric oxide production: a study in Algerian patients. J Interferon Cytokine Res. 2014;34(11):839–47. 10.1089/jir.2013.0085 [DOI] [PubMed] [Google Scholar]
- 40.Benchabane S, Boudjelida A, Toumi R, Belguendouz H, Youinou P, Touil-Boukoffa C. A case for IL-6, IL-17A, and nitric oxide in the pathophysiology of Sjogren's syndrome. Int J Immunopathol Pharmacol. 2016;29(3):386–97. 10.1177/0394632016651273 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.Scholz-Ahrens KE, Ade P, Marten B, Weber P, Timm W, Acil Y, et al. Prebiotics, probiotics, and synbiotics affect mineral absorption, bone mineral content, and bone structure. J Nutr. 2007;137(3 Suppl 2):838S–46S. [DOI] [PubMed] [Google Scholar]
- 42.Zhai Q, Wang G, Zhao J, Liu X, Tian F, Zhang H, et al. Protective effects of Lactobacillus plantarum CCFM8610 against acute cadmium toxicity in mice. Appl Environ Microbiol. 2013;79(5):1508–15. 10.1128/AEM.03417-12 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43.Zhai Q, Wang G, Zhao J, Liu X, Narbad A, Chen YQ, et al. Protective Effects of Lactobacillus plantarum CCFM8610 against Chronic Cadmium Toxicity in Mice Indicate Routes of Protection besides Intestinal Sequestration. Appl Environ Microbiol. 2014;80(13):4063–71. 10.1128/AEM.00762-14 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44.Shrivastava S. The influence of gingerol treatment on aluminum toxicity in rats. J Environ Pathol Toxicol Oncol. 2015;34(1):11–21. [DOI] [PubMed] [Google Scholar]
- 45.Zhang C, Li Y, Wang C, Lv R, Song T. Extremely low-frequency magnetic exposure appears to have no effect on pathogenesis of Alzheimer's disease in aluminum-overloaded rat. PloS one. 2013;8(8):e71087–e. 10.1371/journal.pone.0071087 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46.Zhu X, Perry G, Moreira PI, Aliev G, Cash AD, Hirai K, et al. Mitochondrial abnormalities and oxidative imbalance in Alzheimer disease. J Alzheimers Dis. 2006;9(2):147–53. [DOI] [PubMed] [Google Scholar]
- 47.Li M, Cui J, Gao Y, Zhang W, Sun L, Liu X, et al. Pathological changes and effect on the learning and memory ability in rats exposed to fluoride and aluminum. Toxicol Res-Uk. 2015;4(5):1366–73. [Google Scholar]
- 48.Gilgun-Sherki Y, Melamed E, Offen D. Antioxidant treatment in Alzheimer's disease: current state. J Mol Neurosci. 2003;21(1):1–11. 10.1385/JMN:21:1:1 [DOI] [PubMed] [Google Scholar]
- 49.Javed H, Khan MM, Khan A, Vaibhav K, Ahmad A, Khuwaja G, et al. S-allyl cysteine attenuates oxidative stress associated cognitive impairment and neurodegeneration in mouse model of streptozotocin-induced experimental dementia of Alzheimer's type. Brain Res. 2011;1389:133–42. 10.1016/j.brainres.2011.02.072 [DOI] [PubMed] [Google Scholar]
- 50.Bravo JA, Forsythe P, Chew MV, Escaravage E, Savignac HM, Dinan TG, et al. Ingestion of Lactobacillus strain regulates emotional behavior and central GABA receptor expression in a mouse via the vagus nerve. Proc Natl Acad Sci U S A. 2011;108(38):16050–5. 10.1073/pnas.1102999108 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 51.Ohland CL, Kish L, Bell H, Thiesen A, Hotte N, Pankiv E, et al. Effects of Lactobacillus helveticus on murine behavior are dependent on diet and genotype and correlate with alterations in the gut microbiome. Psychoneuroendocrinology. 2013;38(9):1738–47. 10.1016/j.psyneuen.2013.02.008 [DOI] [PubMed] [Google Scholar]
- 52.Lien do TK, Nhung BT, Khan NC, Hop le T, Nga NT, Hung NT, et al. Impact of milk consumption on performance and health of primary school children in rural Vietnam. Asia Pac J Clin Nutr. 2009;18(3):326–34. [PubMed] [Google Scholar]
- 53.Messaoudi M, Lalonde R, Violle N, Javelot H, Desor D, Nejdi A, et al. Assessment of psychotropic-like properties of a probiotic formulation (Lactobacillus helveticus R0052 and Bifidobacterium longum R0175) in rats and human subjects. Br J Nutr. 2011;105(5):755–64. 10.1017/S0007114510004319 [DOI] [PubMed] [Google Scholar]
- 54.Vorhees CV, Williams MT. Morris water maze: procedures for assessing spatial and related forms of learning and memory. Nat Protoc. 2006;1(2):848–58. 10.1038/nprot.2006.116 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 55.Gareau MG. Microbiota-Gut-Brain Axis and Cognitive Function. In: Lyte M, Cryan JF, editors. Microbial Endocrinology: The Microbiota-Gut-Brain Axis in Health and Disease. Adv Exp Med Biol. 8172014. p. 357–71.
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Data Availability Statement
All relevant data are within the paper.